Acrotech Biopharma

BELEODAQ

Manufacturer:

Acrotech Biopharma

Beleodaq HCPCS:

J9032

HCPCS Code Descriptor:

Injection, belinostat, 10 mg

Category:

J Code

Beleodaq NDCs:

72893-0002-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Beleodaq CPT Codes:

Potential CPT administration codes for Beleodaq can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Beleodaq:

BELEODAQ is an Oncology drug manufactured by Acrotech Biopharma and administered via the Intravenous route of administration. The J Code: J9032 is aligned to the drug BELEODAQ.

ACCESS PRICING AND MORE BY REGISTERING

J9032 Added Date:

January 1, 2016

J9032 Effective Date:

January 1, 2016

J9032 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Beleodaq billing and coding information.
Beleodaq patient assistance information can be found through Acrotech Patient Access at the URL: https://acrotechpatientaccess.com/
BELEODAQ prescribing information can be found at the link below:
Information regarding BELEODAQ’s side effects can be found at MedlinePlus